{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:20:30Z","timestamp":1788848430288,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015 n\u00ba 1533"],"award-info":[{"award-number":["PICT 2015 n\u00ba 1533"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PIDC 2013 048"],"award-info":[{"award-number":["PIDC 2013 048"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017 1554"],"award-info":[{"award-number":["PICT 2017 1554"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00262-020-02787-2","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T17:05:35Z","timestamp":1605200735000},"page":"1519-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epstein\u2013Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma"],"prefix":"10.1007","volume":"70","author":[{"given":"O.","family":"Jimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garcia Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Preciado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"De Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-3859","authenticated-orcid":false,"given":"P.","family":"Chabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"2787_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2013.07.002","volume":"24","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sattarzadeh A, Diepstra A, Visser L, van den Berg A (2014) The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component. Semin Cancer Biol 24:15\u201322","journal-title":"Semin Cancer Biol"},{"key":"2787_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9151-8_1","volume":"1956","author":"M Seifert","year":"2019","unstructured":"Seifert M, Scholtysik R, K\u00fcppers R (2019) Origin and pathogenesis of B cell lymphomas. Methods Mol Biol 1956:1\u201333","journal-title":"Methods Mol Biol"},{"key":"2787_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"2787_CR4","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","volume":"78","author":"EJ Wherry","year":"2004","unstructured":"Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78:5535\u20135545","journal-title":"J Virol"},{"key":"2787_CR5","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B (2015) T-cell exhaustion in the tumor microenvironment. Cell Death Dis 6:e1792","journal-title":"Cell Death Dis"},{"key":"2787_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.blre.2014.09.004","volume":"29","author":"LJ Bryan","year":"2015","unstructured":"Bryan LJ, Gordon LI (2015) Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategy. Blood Rev 29:25\u201332","journal-title":"Blood Rev"},{"key":"2787_CR7","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","volume":"122","author":"R K\u00fcppers","year":"2012","unstructured":"K\u00fcppers R, Engert A, Hansmann ML (2012) Hodgkin lymphoma. J Clin Invest 122:3439\u20133447","journal-title":"J Clin Invest"},{"key":"2787_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.11702","volume":"93","author":"A Tzankov","year":"2008","unstructured":"Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma. Haematologica 93:193\u2013200","journal-title":"Haematologica"},{"key":"2787_CR9","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","volume":"27","author":"J Carreras","year":"2009","unstructured":"Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E (2009) High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27:1470\u20131476","journal-title":"J Clin Oncol"},{"key":"2787_CR10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.humpath.2009.03.025","volume":"40","author":"S Muenst","year":"2009","unstructured":"Muenst S, Hoeller S, Dirnhofer S, Tzankov A (2009) Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival. Hum Pathol 40:1715\u20131722","journal-title":"Hum Pathol"},{"key":"2787_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3324\/haematol.2015.132761","volume":"101","author":"S Vardhana","year":"2016","unstructured":"Vardhana S, Younes A (2016) The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints. Haematologica 101:794\u2013802","journal-title":"Haematologica"},{"key":"2787_CR12","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MG Roemer","year":"2016","unstructured":"Roemer MG, Advani RH, Ligon AH, Natkunam Y, Redd RA, Homer H, Connelly CF, Sun HH, Daadi SE, Freeman GJ, Armand P, Chapuy B, de Jong D, Hoppe RT, Neuberg DS, Rodig SJ, Shipp MA (2016) PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 34:2690\u20132697","journal-title":"J Clin Oncol"},{"key":"2787_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677\u2013704","journal-title":"Annu Rev Immunol"},{"key":"2787_CR14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","volume":"130","author":"CD Carey","year":"2017","unstructured":"Carey CD, Gusenleitner D, Lipschitz M, Roemer MGM, Stack EC, Gjini E, Hu X, Redd R, Freeman GJ, Neuberg D, Hodi FS, Liu XS, Shipp MA, Rodig SJ (2017) Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood 130:2420\u20132430","journal-title":"Blood"},{"key":"2787_CR15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood-2019-122535","volume":"134","author":"SS Patel","year":"2019","unstructured":"Patel SS, Weirather JL, Lipschitz M, Lako A, Chen PH, Griffin GK, Armand P, Shipp MA, Rodig SJ (2019) The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative. Blood 134:2059\u20132069","journal-title":"Blood"},{"key":"2787_CR16","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","volume":"126","author":"J Kiyasu","year":"2015","unstructured":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, Sugita Y, Yufu Y, Choi I, Abe Y, Uike N, Nagafuji K, Okamura T, Akashi K, Takayanagi R, Shiratsuchi M, Ohshima K (2015) Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood 126:2193\u20132201","journal-title":"Blood"},{"key":"2787_CR17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O\u2019Donnell E, Neuberg D, Shipp MA (2012) Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 18:1611\u20131618","journal-title":"Clin Cancer Res"},{"key":"2787_CR18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","volume":"33","author":"K Kataoka","year":"2019","unstructured":"Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronn\u00e9 L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S (2019) Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia 33:1687\u20131699","journal-title":"Leukemia"},{"key":"2787_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/modpathol.2016.202","volume":"30","author":"R Saito","year":"2017","unstructured":"Saito R, Abe H, Kunita A, Yamashita H, Seto Y, Fukayama M (2017) Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications. Mod Pathol 30:427\u2013439","journal-title":"Mod Pathol"},{"key":"2787_CR20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","volume":"9","author":"C Shannon-Lowe","year":"2019","unstructured":"Shannon-Lowe C, Rickinson A (2019) The global landscape of EBV-associated tumors. Front Oncol 9:713","journal-title":"Front Oncol"},{"key":"2787_CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3322\/caac.21438","volume":"68","author":"S Shanbhag","year":"2018","unstructured":"Shanbhag S, Ambinder RF (2018) Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin 68:116\u2013132","journal-title":"CA Cancer J Clin"},{"key":"2787_CR22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3389\/fonc.2019.00881","volume":"9","author":"E De Matteo","year":"2019","unstructured":"De Matteo E, Garc\u00eda Lombardi M, Preciado MV, Chabay P (2019) Changes in EBV association pattern in pediatric classic Hodgkin lymphoma from a single institution in argentina. Front Oncol 9:881","journal-title":"Front Oncol"},{"key":"2787_CR23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.27858","volume":"133","author":"PA Chabay","year":"2013","unstructured":"Chabay PA, Preciado MV (2013) EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region. Int J Cancer 133:1286\u20131292","journal-title":"Int J Cancer"},{"key":"2787_CR24","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.3390\/pathogens7020040","volume":"7","author":"GW Tan","year":"2018","unstructured":"Tan GW, Visser L, Tan LP, van den Berg A, Diepstra A (2018) The microenvironment in epstein-barr virus-associated malignancies. Pathogens 7:E40","journal-title":"Pathogens"},{"key":"2787_CR25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ijc.27314","volume":"131","author":"MH Barros","year":"2012","unstructured":"Barros MH, Vera-Lozada G, Soares FA, Niedobitek G, Hassan R (2012) Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer 131:1142\u20131152","journal-title":"Int J Cancer"},{"key":"2787_CR26","doi-asserted-by":"crossref","first-page":"e0124531","DOI":"10.1371\/journal.pone.0124531","volume":"10","author":"MH Barros","year":"2015","unstructured":"Barros MH, Segges P, Vera-Lozada G, Hassan R, Niedobitek G (2015) Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival. PLoS ONE 10:e0124531","journal-title":"PLoS ONE"},{"key":"2787_CR27","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1038\/s41598-019-49015-1","volume":"9","author":"O Jimenez","year":"2019","unstructured":"Jimenez O, Barros MH, De Matteo E, Garcia Lombardi M, Preciado MV, Niedobitek G, Chabay P (2019) M1-like macrophage polarization prevails in young children with classic Hodgkin Lymphoma from Argentina. Sci Rep 9:12687","journal-title":"Sci Rep"},{"key":"2787_CR28","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390","journal-title":"Blood"},{"key":"2787_CR29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20160801","volume":"214","author":"VR Juneja","year":"2017","unstructured":"Juneja VR, McGuire KA, Manguso RT, LaFleur MW, Collins N, Haining WN, Freeman GJ, Sharpe AH (2017) PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J Exp Med 214:895\u2013904","journal-title":"J Exp Med"},{"key":"2787_CR30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41379-018-0193-5","volume":"32","author":"L Li","year":"2019","unstructured":"Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam G, Tan X, Zhang H, Xiao M, Tzankov A, Visco C, Dybkaer K, Bhagat G, Tam W, Hsi E, van Krieken J, You H, Huh J, Ponzoni M, Ferreri A, Moller M, Piris M, Zhang M, Winter J, Medeiros L, Rassidakis G, Vaupel C, Li Y, Dakappagari N, Xu-Monette Z, Young K (2019) PD-1\/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program. Mod Pathol 32:741\u2013754","journal-title":"Mod Pathol"},{"key":"2787_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40880-017-0262-z","volume":"36","author":"Hu Li-Yang","year":"2017","unstructured":"Li-Yang Hu, Xiao-Lu Xu, Rao H-L, Chen J, Lai R-C, Huang H-Q, Jiang W-Q, Lin T-Y, Xia Z-J, Cai Q-Q (2017) Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study. Chin J Cancer 36:94","journal-title":"Chin J Cancer"},{"key":"2787_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41408-019-0233-5","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wenzl K, Manske M, Asmann Y, Sarangi V, Greipp P, Krull J, Hartert K, He R, Feldman A, Maurer M, Slager S, Nowakowski G, Habermann T, Witzig T, Link B, Ansell S, Cerhan J, Novak A (2019) Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma. Blood Cancer J 9:73","journal-title":"Blood Cancer J"},{"key":"2787_CR33","doi-asserted-by":"crossref","first-page":"e27571","DOI":"10.1002\/pbc.27571","volume":"66","author":"M Dilly-Feldis","year":"2019","unstructured":"Dilly-Feldis M, Aladjidi N, Refait J, Parrens M, Ducassou S, Rullier A (2019) Expression of PD-1\/PD-L1 in children\u2019s classical Hodgkin lymphomas. Pediatr Blood Cancer 66:e27571","journal-title":"Pediatr Blood Cancer"},{"key":"2787_CR34","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1038\/s41598-017-11052-z","volume":"7","author":"M Cohen","year":"2017","unstructured":"Cohen M, Vistarop AG, Huaman F, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA (2017) Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact. Sci Rep 7:10813","journal-title":"Sci Rep"},{"key":"2787_CR35","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","volume":"111","author":"R Yamamoto","year":"2008","unstructured":"Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, Tashima M, Kondo T, Ohmori K, Kurata M, Hayashi T, Uchiyama T (2008) PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111:3220\u20133224","journal-title":"Blood"},{"key":"2787_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00430-018-0553-2","volume":"207","author":"AG Vistarop","year":"2018","unstructured":"Vistarop AG, Cohen M, Huaman F, Irazu L, Rodriguez M, De Matteo E, Preciado MV, Chabay PA (2018) The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control. Med Microbiol Immunol 207:319\u2013327","journal-title":"Med Microbiol Immunol"},{"key":"2787_CR37","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.4049\/jimmunol.179.12.8225","volume":"179","author":"S Lambert","year":"2007","unstructured":"Lambert S, Martinez O (2007) Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol 179:8225\u20138234","journal-title":"J Immunol"},{"key":"2787_CR38","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2017-06-781989","volume":"130","author":"W Liu","year":"2017","unstructured":"Liu W, Shipp M (2017) Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma. Blood 130:2265\u20132270","journal-title":"Blood"},{"key":"2787_CR39","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-14-3016","volume":"75","author":"Z Sun","year":"2015","unstructured":"Sun Z, Fourcade J, Pagliano O, Chauvin JM, Sander C, Kirkwood JM, Zarour HM (2015) IL10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T cells. Cancer Res 75:1635\u20131644","journal-title":"Cancer Res"},{"key":"2787_CR40","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.2019000889","volume":"134","author":"A Cristino","year":"2019","unstructured":"Cristino A, Nourse J, West R, Sabdia M, Law S, Gunawardana J, Vari F, Mujaj S, Thillaiyampalam G, Snell C, Gough M, Keane C, Gandhi M (2019) EBV microRNA-BHRF1-2-5p Targets the 3\u2019UTR of immune checkpoint ligands PD-L1 and PD-L2. Blood 134:2261\u20132270","journal-title":"Blood"},{"key":"2787_CR41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/his.13857","volume":"75","author":"L Veloza","year":"2019","unstructured":"Veloza L, Teixido C, Castrejon N, Climent F, Carri\u00f3 A, Marginet M, Soldini D, Gonz\u00e1lez-Farr\u00e9 B, Ribera-Cortada I, Lopez-Guillermo A, Gonz\u00e1lez-Barca C, Sierra A, Herrera M, G\u00f3mez C, Garcia A, Balagu\u00e9 O, Campo E, Martinez A (2019) Clinicopathological evaluation of the programmed cell death 1 (PD1)\/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with epstein-barr virus, PD-L1 copy number alterations, and outcome. Histopathology 75:799\u2013812","journal-title":"Histopathology"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02787-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T04:05:08Z","timestamp":1621656308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02787-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02787-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional guidelines regarding human experimentation were followed, according to the Helsinki Declaration of 1975. The protocol was approved by the Ethical Committee of Ricardo Gutierrez Children Hospital, and written informed assent and consent was obtained from all patients or patient\u00b4s parents depending on age.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}